The National Institute for Health and Clinical Excellence (NICE) seeks members for a Guideline Development Group - members will work on the forthcoming Clinical Guidance on the Recognition and Initial Management of Ovarian Cancer.
This important guidance which will be published in 2011 is likely to cover issues such as
- Awareness of symptoms both amongst both health professionals and the general public
- The role of symptoms and various diagnostic tests for determining who should undergo urgent referral
- The intial treatment (including surgery and chemotherapy) for women diagnosed with ovarian cancer
As a registered stakeholder Target Ovarian Cancer has already participated in a workshop to help prepare the draft scope for the guidance. This draft scope is to be published shortly and there will be a period of consultation during which we and any other interested parties feedback further comments. The final scope is then prepared.
The Guideline Development Group which consists of a range of health professionals and patients/carers/patient organisations under the lead of the National Collaborating Centre for Cancer will then be charged with reviewing all available evidence and drafting the proposed guidelines which will then once again go out for consultation.
Any person can apply to become a member of the Guideline Development Group whether as a health professional or patient/carer/patient organisation (lay member). For professionals the closing date is 24th Feb 2009 and for lay members 10th March 2009. Our website will bring you any important news about the process and other opportunities to contribute.